ABC | Volume 113, Nº3, Setembro 2019

Atualização Atualização da Diretriz de Ressuscitação Cardiopulmonar e Cuidados Cardiovasculares de Emergência da Sociedade Brasileira de Cardiologia – 2019 Arq Bras Cardiol. 2019; 113(3):449-663 technicians in patients with asystolic cardiac arrest. N Engl J Med. 1993;328(19):1377-82. 316. Madias C, Maron BJ, Alsheikh-Ali AA, Rajab M, Estes NA 3rd, Link MS. Precordial thump for cardiac arrest is effective for asystole but not for ventricular fibrillation. Heart Rhythm. 2009;6(10):1495-500. 317. Miller J, TreschD, Horwitz L, Thompson BM, AprahamianC, Darin JC. The precordial thump. Ann Emerg Med. 1984;13(9 Pt 2):791-4. 318. Haman L, Parizek P, Vojacek J. Precordial thump efficacy in termination of induced ventricular arrhythmias. Resuscitation. 2009;80(1):14-6. 319. Deakin CD, Nolanb JP, Soarc J, Sunded K, Kostere RW, Smith GB, et al. European ResuscitationCouncil Guidelines for Resuscitation 2010 Section 4. Adult advanced life support. Resuscitation. 2010;81(10):1305-52. 320. Mangrum JM, DiMarco JP. The evaluation and management of bradycardia. N Engl J Med. 2000;342(10):703-9. 321. Mancini ME, Soar J, Bhanji F, Billi JE, Dennett J, Finn J, et al. Part 12: Education, Implementation, and Teams: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2010;122(16 Suppl 2):S539-81. 322. Nolan J, Smith G, Evans R, McCusker K, Lubas P, Parr M, et al. The United Kingdom pre-hospital study of active compression decompression resuscitation. Resuscitation. 1998;37(2):119-25. 323. Mandal A. Que é bradicardia? [Internet] [Citado 2010 fev 22] Disponível em http://www. news-medical.net/health/Bradycardia-Causes- (Portuguese).aspx. 324. Thomsen JH, Nielsen N, Hassager C, Wanscher M, Pehrson S, Køber L, et al.Bradycardiaduringtargetedtemperaturemanagement:anearlymarker of lower mortality and favorable neurologic outcome in comatose out-of- hospital cardiac arrest patients. Crit Care Med. 2016;44(2):308-18. 325. Staer-JensenH,SundeK,OlasveengenTM, JacobsenD,DrægniT,Nakstad ER, et al. Bradycardia during therapeutic hypothermia is associated with good neurologic outcome in comatose survicors of out-of-hospital cardiac arrest. Crit Care Med. 2014;42(11):2401-8. 326. Furman S, Hayers D, Holmes D. A practice of cardiac pacing. New York: Futura Publishing; 1986. 327. Smith I, Monk TG, White PF. Comparison of transesophageal atrial pacing with anticholinergic drugs for the treatment of intraoperative bradycardia. Anesth Analg. 1994;78(2):245-52. 328. Brady WJ, Swart G, DeBehnke DJ, Ma OJ, Aufderheide TP. The efficacy of atropine in the treatment of hemodynamically unstable bradycardia and atrioventricular block: prehospital and emergency department considerations. Resuscitation. 1999;41(1):74-55. 329. Dauchot P, Gravenstein JS. Effects of atropine on the eletrocardiogram in different age groups. Clin Pharmacol Ther. 1971;12(2):274-80. 330. Bektas F, Soyuncu S. The efficacy of transcutaneous cardiac pacing in ED. Am J Emerg Med. 2016;34(11):2090-3. 331. Mehta D, Wafa S, Ward DE, Camm AJ. Relative efficacy of various physical manoeuvres in the termination of junctional tachycardia. Lancet. 1988;1(8596):1181-5. 332. Engelstein ED, Lippman N, Stein KM, Lerman BB. Mechanism- specific effects of adenosine on atrial tachycardia. Circulation. 1994;89(6):2645-54. 333. Markowitz SM, Stein KM, Mittal S, Slotwiner DJ, Lerman BB. Differential effects of adenosine on focal and macroreentrant atrial tachycardia. J Cardiovasc Electrophysiol. 1999;10(4):489-502. 334. Stock JP. Beta adrenergic blocking drugs in the clinical management of cardiac arrhythmias. Am J Cardiol. 1966;18(3):444-9. 335. Steinbeck G, Hoffmann E. 'True' atrial tachycardia. Eur Heart J. 1998;19 (Suppl E):E10-2, E48-9. 336. Lim SH, Anantharaman V, Teo WS, Goh PP, Tan AT. Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage. Ann Emerg Med. 1998;31(1):30-5. 337. Wen ZC, Chen SA, Tai CT, Chiang CE, Chiou CW, Chang MS, et al. Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia. Circulation. 1998;98(24):2716-23. 338. Derbes VJ, Kerr A. Valsalva's maneuver and Weber's experiment. N Engl J Med. 1955;253(19):822-3. 339. Smith GD, Fry MM, Morgans A, Cantwell K. Effectiveness of the Valsalva manoeuvre for reversion of supraventricular tachycardia. Cochrane Database Syst Rev. 2015 Feb 18;(2):CD009502. 340. Davies AJ, Kenny RA. Frequency of neurologic complications following carotid sinus massage. Am J Cardiol. 1998;81(10):1256-7. 341. Cheng KA.; Intravenous Adenosine versus Verapamil in Terminating Episodes of Paroxysmal Supraventricular Tachycardia Study Group. A randomized, multicenter trial to compare the safety and efficacy of adenosineversusverapamil forterminationofparoxysmalsupraventricular tachycardia. Zhonghua Nei Ke Za Zhi. 2003;42(11):773-6. 342. Hood MA, Smith WM. Adenosine versus verapamil in the treatment of supraventricular tachycardia: a randomized double-crossover trial. Am Heart J. 1992;123(6):1543-9. 343. Rankin AC, Oldroyd KG, Chong E, Dow JW, Rae AP, Cobbe SM. Adenosine or adenosine triphosphate for supraventricular tachycardias? Comparative double-blind randomized study in patients with spontaneous or inducible arrhythmias. AmHeart J. 1990;119(2 Part 1):316-23. 344. Biaggioni I, Olafsson B, Robertson RM, Hollister AS, Robertson D. Cardiovascular and respiratory effects of adenosine in conscious man: evidence for chemoreceptor activation. Circ Res. 1987;61(6):779-86. 345. Kaplan IV, Kaplan AV, Fisher JD. Adenosine induced atrial fibrillation precipitating polymorphic ventricular tachycardia. Pacing Clin Electrophysiol. 2000;23(1):140-1. 346. Gupta AK, Shah CP, Maheshwari A, Thakur RK, Hayes OW, Lokhandwala YY. Adenosine induced ventricular fibrillation in Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol. 2002;25(4 Pt 1):477-80. 347. Ross DL, Uther JB. Diagnosis of concealed accessory pathways in supraventricular tachycardia. Pacing Clin Electrophysiol. 1984;7(6 Pt 1):1069-85. 348. Poutiainen AM, Koistinen MJ, Airaksinen KE, Hartikainen EK, Kettunen RV, Karjalainen JE, et al. Prevalence and natural course of ectopic atrial tachycardia. Eur Heart J. 1999;20(9):694-700. 349. Olshansky B, Rosenfeld LE,Warner AL, et al. The Atrial Fibrillation Follow- up Investigation of RhythmManagement (AFFIRM) study: approaches to control rate in atrial fibrillation. J Am Coll Cardiol. 2004;43(7):1201-8. 350. Gupta A, Naik A, Vora A, Lokhandwala Y. Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia. J Assoc Physicians India. 1999;47(10):969-72. 351. Olukotun AY, Klein GJ. Efficacy and safety of intravenous nadolol for supraventricular tachycardia. Am J Cardiol. 1987;60(6):59D-62D. 352. AndersonS,BlanskiL,ByrdRC,DasG,EnglerR,LadduA,etal.Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. AmHeart J. 1986;111(1):42-8. 353. Wesley RC Jr, Haines DE, Lerman BB, DiMarco JP, Crampton RS. Effect of intravenous magnesium sulfate on supraventricular tachycardia. Am J Cardiol. 1989;63(15):1129-31. 354. Joshi PP, Deshmukh PK, Salkar RG. Efficacy of intravenous magnesium sulphate in supraventricular tachyarrhythmias. J Assoc Physicians India. 1995;43(8):529-31. 634